Robert E. Kiss
Director/Board Member at Biotechnology Innovation Organization
Profile
Mr. Robert E.
Kiss, CFA, is a Managing Director & Portfolio Manager at J.P.
Morgan Investment Management Ltd.
He is on the Board of Directors at Biotechnology Industry Organization.
Mr. Kiss also served on the board at CancerVax Corp.
and Micromet, Inc.
He received his undergraduate degree from Lehigh University.
Robert E. Kiss active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Former positions of Robert E. Kiss
| Companies | Position | End |
|---|---|---|
| CancerVax Corp. | Director/Board Member | 2006-05-08 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director/Board Member | 2006-05-04 |
J.P. Morgan Investment Management Ltd.
 J.P. Morgan Investment Management Ltd. Investment ManagersFinance J.P. Morgan Investment Management Ltd. provides investment banking and financial services It also offers commercial banking, financial transaction processing, asset management, and private equity services. The company was founded on April 28, 2000 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Training of Robert E. Kiss
| Lehigh University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
| CancerVax Corp. | Commercial Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
J.P. Morgan Investment Management Ltd.
J.P. Morgan Investment Management Ltd. Investment ManagersFinance J.P. Morgan Investment Management Ltd. provides investment banking and financial services It also offers commercial banking, financial transaction processing, asset management, and private equity services. The company was founded on April 28, 2000 and is headquartered in London, the United Kingdom. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
- Stock Market
- Insiders
- Robert E. Kiss